Itama Ranoraya (IRRA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Itama Ranoraya (IRRA) has a cash flow conversion efficiency ratio of -0.502x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-270.56 Billion ≈ $-15.85 Million USD) by net assets (Rp538.82 Billion ≈ $31.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Itama Ranoraya liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Itama Ranoraya - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Itama Ranoraya's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Itama Ranoraya Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Itama Ranoraya ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
JAS Asset PCL
BK:J
|
0.016x |
|
InspireMD Inc
NASDAQ:NSPR
|
-0.283x |
|
Avonmore Capital & Management Services Limited
NSE:AVONMORE
|
0.002x |
|
Reckon Ltd
AU:RKN
|
0.538x |
|
Latrobe Magnesium Ltd
AU:LMG
|
0.060x |
|
Duksung
KO:004830
|
0.014x |
|
Truong Thanh Furniture Corp
VN:TTF
|
N/A |
|
Avertronics
TWO:3597
|
0.003x |
Annual Cash Flow Conversion Efficiency for Itama Ranoraya (2016–2024)
The table below shows the annual cash flow conversion efficiency of Itama Ranoraya from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see IRRA company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp512.31 Billion ≈ $30.02 Million |
Rp-430.13 Billion ≈ $-25.20 Million |
-0.840x | -924.52% |
| 2023-12-31 | Rp459.20 Billion ≈ $26.91 Million |
Rp-37.63 Billion ≈ $-2.21 Million |
-0.082x | -171.33% |
| 2022-12-31 | Rp484.04 Billion ≈ $28.36 Million |
Rp55.61 Billion ≈ $3.26 Million |
0.115x | +153.99% |
| 2021-12-31 | Rp502.05 Billion ≈ $29.42 Million |
Rp-106.83 Billion ≈ $-6.26 Million |
-0.213x | -135.06% |
| 2020-12-31 | Rp242.33 Billion ≈ $14.20 Million |
Rp147.09 Billion ≈ $8.62 Million |
0.607x | +1844.88% |
| 2019-12-31 | Rp235.17 Billion ≈ $13.78 Million |
Rp-8.18 Billion ≈ $-479.35K |
-0.035x | +74.92% |
| 2018-12-31 | Rp66.64 Billion ≈ $3.91 Million |
Rp-9.25 Billion ≈ $-541.73K |
-0.139x | -119.52% |
| 2017-12-31 | Rp44.35 Billion ≈ $2.60 Million |
Rp31.51 Billion ≈ $1.85 Million |
0.711x | +619.39% |
| 2016-12-31 | Rp10.78 Billion ≈ $631.71K |
Rp1.06 Billion ≈ $62.40K |
0.099x | -- |
About Itama Ranoraya
PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical … Read more